FDA Inspection 571882 — Hubei Biocause Heilen Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Biocause Heilen Pharmaceutical Co., Ltd. on March 4, 2009 in Jingmen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 4, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jingmen (China)